PB

Patricia Bronke Mcnamara

Active Director Director DIN 10450467
DIN 10450467 First appointment Oct 2024 Primary industry Business Outsourcing
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value •••• Premium profile

About Patricia Bronke Mcnamara

Data last updated:

Patricia Bronke Mcnamara is a Director at Flex And Oncology Clinical Research Private Limited (since 2024). The company operates in Business Outsourcing. Flex And Oncology Clinical Research Private Limited reported revenue of ₹33.24 Cr (FY 2025).

DIN 10450467
Primary Designation Director
Industry Business Outsourcing
First Appointment 28 Oct 2024
Oldest Company Age 7 yrs
Largest company Flex And Oncology Clinical Research Private Limited · ₹33.24 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Oct 20242019₹33.24 Cr (FY 2025)Active

Board colleagues of Patricia Bronke Mcnamara

Directorship timeline

Open interactive timeline →
Flex And Oncology Clinical Research Private Limited
Premium access

Shareholding and investment profile for Patricia Bronke Mcnamara

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Patricia Bronke Mcnamara

Patricia Bronke Mcnamara currently holds 1 directorship: Flex And Oncology Clinical Research Private Limited (Director, since 28 Oct 2024, revenue ₹33.24 Cr (FY 2025)).

Patricia Bronke Mcnamara was first appointed on 28 Oct 2024 as Director at Flex And Oncology Clinical Research Private Limited.

The current boards of Patricia Bronke Mcnamara's companies include Sindhu Bhaskaran Pillai (Flex And Oncology Clinical Research Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available